Moss, 28 February 2019
Gentian Diagnostics AS announces its results for the 4th quarter and 2018 preliminary annual results. The highlights include:
- Record sales revenues of MNOK 11.1 for the quarter
- 42 % growth in underlying sales revenue compared to 4Q17, 43 % year to date
- All time high sales results achieved with fCAL® turbo
For further information, please contact: